Cost-effectiveness analysis of collaborative treatment of late-life depression in primary care (GermanIMPACT).

CONCLUSION: Evidence for cost-effectiveness of GermanIMPACT relative to treatment as usual is not clear. Only if societal WTP was ≥€180 for an additional DFD, GermanIMPACT could be considered cost-effective with certainty. PMID: 30658275 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30658275?dopt=Abstract

Source: Journal of the Association of European Psychiatrists - January 19, 2019 Category: Psychiatry Tags: Eur Psychiatry Source Type: research